American Healthcare REIT
AHR
49.37
-1.12
-2.22%
American Healthcare REIT
US · AHR
#1336 by market cap
Listed 2024
49.37
-1.12
-2.22%
Live - 5344 symbols - heartbeat 218s ago
· 2026-10-07 20:02
After-hours
48.75
-1.26%
- Market cap
- 11.42B
- P/E (TTM)i
- 72.60
- P/Bi
- 3.09
- EPSi
- 0.42
- Div yieldi
- 2.03%
- 52W posi
- 52%
Reader sentiment
Are you bullish or bearish on AHR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.32, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 6 years
Latest year +9.15% YoY
Margins
- Gross margin
- 20.64%
- Operating margin
- 7.47%
- Net margin
- 3.09%
Key ratios & quality
- Enterprise valuei
- 12.85B
- Altman Z-Scorei
- 3.32
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 1.24B | 1.28B | 1.64B | 1.87B | 2.07B | 2.26B |
| Gross profit | 195.39M | 235.11M | 335.97M | 356.83M | 416.78M | 466.59M |
| Selling & admin expenses | 59.31M | 81.92M | 103.10M | 104.99M | 100.80M | 110.17M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 92.41M | 36.95M | 90.59M | 76.72M | 136.79M | 168.87M |
| Pretax profit | 5.79M | -52.31M | -72.80M | -76.22M | -33.89M | 48.65M |
| Tax | -3.08M | 956.00K | 586.00K | 663.00K | 1.71M | -22.17M |
| Net profit | 8.86M | -53.27M | -73.38M | -76.89M | -35.60M | 70.82M |
| Basic EPS | 0 | -1 | -1 | -1 | 0 | 0 |
| Diluted EPS | 0.03 | -0.72 | -1.23 | -1.08 | -0.29 | 0.42 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 540.60M | 542.50M | 572.94M | 604.08M | 650.77M | 674.25M |
| Gross profit | 108.18M | 116.22M | 118.41M | 123.79M | 138.60M | 149.41M |
| Selling & admin expenses | 26.80M | 27.93M | 26.70M | 28.74M | 30.71M | 32.06M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 40.27M | 46.34M | 42.53M | 39.73M | 40.84M | 45.22M |
| Pretax profit | -6.24M | 10.81M | 35.55M | 8.53M | 23.49M | 30.98M |
| Tax | 604.00K | 732.00K | -21.09M | -2.42M | -525.00K | -3.00K |
| Net profit | -6.84M | 10.08M | 56.64M | 10.94M | 24.01M | 30.98M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.04 | 0.06 | 0.33 | 0.06 | 0.13 | 0.16 |
Balance sheet
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total current assets | -- | 267.19M | 269.18M | 297.10M | 354.90M | 374.90M |
| Cash & ST investments | -- | 81.60M | 65.05M | 43.45M | 76.70M | 114.84M |
| Inventory | -- | 18.93M | 19.78M | 19.47M | 19.48M | 18.84M |
| Total assets | -- | 4.58B | 4.79B | 4.58B | 4.49B | 5.43B |
| Total current liabilities | -- | 1.41B | 1.53B | 1.47B | 946.86M | 867.50M |
| Short-term debt | -- | 1.23B | 1.28B | 1.22B | 688.53M | 549.76M |
| Long-term debt | -- | 1.13B | 1.28B | 1.34B | 1.02B | 1.00B |
| Total liabilities | -- | 2,750,768,000.00 | 3,137,335,000.00 | 3,118,755,000.00 | 2,183,895,000.00 | 2,065,611,000.00 |
| Total equity | -- | 1.83B | 1.65B | 1.46B | 2.30B | 3.36B |
| Retained earnings | -- | -951.30M | -1.14B | -1.28B | -1.46B | -1.56B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 370.05M | 414.02M | 393.38M | 374.90M | 419.52M | 442.72M |
| Cash & ST investments | 86.06M | 133.49M | 147.36M | 114.84M | 119.38M | 156.90M |
| Inventory | 19.37M | 19.43M | 20.24M | 18.84M | 20.44M | 20.51M |
| Total assets | 4.46B | 4.51B | 4.77B | 5.43B | 5.60B | 5.70B |
| Total current liabilities | 914.84M | 823.33M | 847.75M | 867.50M | 890.08M | 882.02M |
| Short-term debt | 642.57M | 549.63M | 549.70M | 549.76M | 549.82M | 549.87M |
| Long-term debt | 1.04B | 1.02B | 1.01B | 1.00B | 996.05M | 892.68M |
| Total liabilities | 2,159,343,000.00 | 2,044,006,000.00 | 2,050,359,000.00 | 2,065,611,000.00 | 2,077,303,000.00 | 1,962,027,000.00 |
| Total equity | 2.30B | 2.46B | 2.72B | 3.36B | 3.52B | 3.74B |
| Retained earnings | -1.50B | -1.54B | -1.52B | -1.56B | -1.58B | -1.60B |
Cash flow
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | 219.16M | 17.91M | 147.77M | 98.54M | 176.09M | 294.44M |
| Depreciation & amortization | 129.65M | 157.38M | 200.60M | 237.30M | 221.64M | 225.20M |
| Free cash flow | 90.85M | -61.78M | 76.25M | -1.26M | 84.15M | 165.88M |
| Dividends paid | -27.00M | -22.79M | -51.12M | -76.28M | -120.90M | -163.52M |
| Stock buybacks / issuance | -23.11M | -382.00K | -20.70M | -469.00K | 1.36B | 1.16B |
| Ending cash balance | 152.19M | 125.49M | 111.91M | 90.78M | 123.30M | 151.75M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 60.62M | 71.48M | 107.19M | 55.17M | 81.07M | 118.62M |
| Depreciation & amortization | 50.93M | 51.34M | 58.72M | 64.21M | 75.99M | 81.16M |
| Free cash flow | 39.44M | 44.58M | 74.83M | 7.03M | 42.75M | 70.93M |
| Dividends paid | -39.55M | -39.88M | -41.24M | -42.86M | -46.82M | -47.61M |
| Stock buybacks / issuance | 47.67M | 188.63M | 243.28M | 676.70M | 191.55M | 229.22M |
| Ending cash balance | 127.45M | 169.99M | 184.36M | 151.75M | 156.88M | 191.62M |
Returns & efficiency
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -3.02 | -5.45 | -5.35 | -2.14 | 2.50 |
| ROA %i | -- | -1.04 | -1.74 | -1.53 | -0.83 | 1.41 |
| ROIC %i | -- | 0.28 | -0.06 | 1.20 | 1.40 | 2.92 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -2.69 |
| EBIT margin %i | 6.48 | 2.26 | 2.05 | 4.68 | 4.53 | 5.95 |
| FCF / sales %i | 7.64 | -- | 4.71 | -- | 4.06 | 7.34 |
| Current ratioi | -- | 0.19 | 0.18 | 0.20 | 0.37 | 0.43 |
| Quick ratioi | -- | 0.14 | 0.13 | 0.16 | 0.30 | 0.37 |
| Debt / assetsi | -- | 54.61 | 59.19 | 61.02 | 41.68 | 31.07 |
| LT debt / equityi | -- | 80.61 | 110.80 | 123.56 | 52.28 | 34.22 |
| Interest coveragei | 1.08 | 0.35 | 0.31 | 0.53 | 0.73 | 1.57 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 16.06 | 17.84 | 11.80 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | 29.57 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -1.93 | -1.51 | 1.12 | 2.50 | 3.49 | 3.96 |
| ROA %i | -0.89 | -0.72 | 0.58 | 1.41 | 1.99 | 2.37 |
| ROIC %i | 1.07 | 1.12 | 2.28 | 2.92 | 3.23 | 3.57 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 3.64 | 3.54 | 4.75 | 5.95 | 6.75 | 7.04 |
| FCF / sales %i | 7.08 | 7.12 | 8.58 | 7.34 | 7.14 | 7.82 |
| Current ratioi | 0.40 | 0.50 | 0.46 | 0.43 | 0.47 | 0.50 |
| Quick ratioi | 0.34 | 0.43 | 0.40 | 0.37 | 0.41 | 0.44 |
| Debt / assetsi | 41.02 | 38.07 | 35.56 | 31.07 | 29.95 | 27.48 |
| LT debt / equityi | 52.54 | 48.17 | 42.82 | 34.22 | 32.37 | 27.54 |
| Interest coveragei | 0.67 | 0.72 | 1.08 | 1.57 | 1.96 | 2.27 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Integrated Senior Health Campuses (ISHC) is the largest reported line at 76.07% of revenue, across 4 reported segments.
- The next-largest line, Senior housing operating properties (SHOP), is a distant second at 18.04% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Integrated Senior Health Campuses (ISHC)76.07%
Senior housing operating properties (SHOP)18.04%
Outpatient Medical (OM)4.45%
Triple-Net Leased Properties1.45%
Quote time 2026-10-07 20:02:23 · For reference only, not investment advice and not tailored to your situation.